Researchers developed and validated a new clinically relevant endpoint, Pancreatic Surgery Composite Endpoint (PACE), for pancreatic surgery. PACE incorporates postoperative pancreatic fistula, post-pancreatectomy hemorrhage, reoperation, and reinterventions. It demonstrated high predictive value for prolonged length of hospital stay (LOS) and mortality in both the development and validation cohorts. PACE allowed for significant reduction in sample sizes and can be effectively used in future prospective trials, offering improved feasibility compared to single outcome measures.
Journal Article by Nickel F, Kuemmerli C (…) Büchler MW et 9 al. in Ann Surg
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.